ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results

LOS ANGELES, March 13, 2018 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC) today announced financial results for the fourth quarter and full year ended December 31, 2017. Anthony J. Gringeri, PhD, President and Chief Executive Officer...